Aclaris Therapeutics (ACRS) Earnings Date, Estimates & Call Transcripts → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free acrs Stock Alerts $1.17 -0.05 (-4.10%) (As of 05:21 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 27) -$0.30 Beat By $0.07 Consensus EPS (Feb. 27) -$0.37 Get Aclaris Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ACRS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACRS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Aclaris Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.35)($0.31)($0.32)Q2 20243($0.26)($0.23)($0.25)Q3 20243($0.21)($0.20)($0.21)Q4 20243($0.21)($0.18)($0.19)FY 202412($1.03)($0.92)($0.97)Q1 20252($0.22)($0.14)($0.18)Q2 20252($0.23)($0.13)($0.18)Q3 20252($0.25)($0.16)($0.21)Q4 20252($0.27)($0.18)($0.23)FY 20258($0.97)($0.61)($0.79)ACRS Earnings Date and InformationAclaris Therapeutics last posted its earnings data on February 27th, 2024. The biotechnology company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.07. The firm had revenue of $17.57 million for the quarter, compared to the consensus estimate of $3.96 million. Aclaris Therapeutics has generated ($1.27) earnings per share over the last year (($1.27) diluted earnings per share). Earnings for Aclaris Therapeutics are expected to grow in the coming year, from ($0.98) to ($0.87) per share. Aclaris Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More Aclaris Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/27/2024Q4 2023($0.37)($0.30)+$0.07($0.58)$3.96 million$17.57 million11/6/2023Q3 2023($0.48)($0.41)+$0.07($0.41)$1.57 million$9.30 million8/7/2023Q2 2023($0.45)($0.42)+$0.03($0.42)$1.90 million$1.90 million5/8/2023Q1 2023($0.44)($0.42)+$0.02($0.42)$1.75 million$2.50 million 2/23/2023Q4 2022($0.44)($0.41)+$0.03($0.41)$1.99 million$7.80 million11/8/2022Q3 2022($0.39)($0.30)+$0.09($0.30)$1.61 million$19.02 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($0.36)($0.31)+$0.05($0.31)$1.59 million$1.53 million5/10/2022Q1 2022($0.39)($0.31)+$0.08($0.31)$1.67 million$1.45 million 2/24/2022Q4 2021($0.36)($0.37)($0.01)($0.37)$1.80 million$1.50 million 11/2/2021Q3 2021($0.28)($0.35)($0.07)($0.35)$1.82 million$1.66 million8/4/2021Q2 2021($0.28)($0.34)($0.06)($0.34)$1.78 million$1.82 million5/6/2021Q1 2021($0.30)($0.57)($0.27)($0.57)$1.47 million$1.78 million Aclaris Therapeutics Earnings - Frequently Asked Questions When is Aclaris Therapeutics's earnings date? Aclaris Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on ACRS's earnings history. Did Aclaris Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aclaris Therapeutics (NASDAQ:ACRS) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.07. Learn more on analysts' earnings estimate vs. ACRS's actual earnings. How much revenue does Aclaris Therapeutics generate each year? Aclaris Therapeutics (NASDAQ:ACRS) has a recorded annual revenue of $31.25 million. How much profit does Aclaris Therapeutics generate each year? Aclaris Therapeutics (NASDAQ:ACRS) has a recorded net income of -$88.48 million. ACRS has generated -$1.27 earnings per share over the last four quarters. What is Aclaris Therapeutics's EPS forecast for next year? Aclaris Therapeutics's earnings are expected to grow from ($0.98) per share to ($0.87) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CLSD Earnings Date DMAC Earnings Date PMVP Earnings Date CMRX Earnings Date BTAI Earnings Date ETON Earnings Date ONCY Earnings Date AFMD Earnings Date ALLK Earnings Date QTTB Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ACRS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
